SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-057433
Filing Date
2018-11-06
Accepted
2018-11-06 08:31:01
Documents
4
Period of Report
2018-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv506435_8k.htm 8-K 19840
2 EXHIBIT 99.1 tv506435_ex99-1.htm EX-99.1 22192
3 GRAPHIC image_001.jpg GRAPHIC 2954
4 GRAPHIC image_002.jpg GRAPHIC 2561
  Complete submission text file 0001144204-18-057433.txt   51388
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 181161607
SIC: 2834 Pharmaceutical Preparations